In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...

A first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide (an anti-inflammatory ...

Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.

Inhaled short acting beta-2 agonists, such as salbutamol or terbutaline, are commonly used as bronchodilators to relieve these symptoms. They can be used regularly or only when needed and are often ...

The Business Research Company's Asthma and COPD Drugs Market 2025: Strategic Insights for Growth, Expansion, and Gaining Competitive Edge It will grow to $50.99 billion in 2029 at a compound annual ...

“However, through our extensive analysis, we found that the incidence of death among cattle administered beta agonists was 75 to 90 percent greater than cattle not administered the beta agonists,” ...

G protein-coupled receptors (GPCRs) represent the targets of more than 30% of the drugs currently on the market. However, ...